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Abstract
The processing of Amyloid precursor protein (APP) is multifaceted, comprising of protein transport, internalization and
sequential proteolysis. However, the exact mechanism of APP intracellular trafficking and distribution remains unclear. To
determine the interaction between sortilin and APP and the effect of sortilin on APP trafficking and processing, we studied
the binding site and its function by mapping experiments, colocalization, coimmunoprecipitation and sucrose gradient
fractionation. We identified for the first time that sortilin interacts with APP at both N- and C-terminal regions. The sortilin-
FLVHRY (residues 787–792) and APP-NPTYKFFE (residues 759–766) motifs are crucial for the C-terminal interaction. We also
found that lack of the FLVHRY motif reduces APP lysosomal targeting and increases APP distribution in lipid rafts in co-
transfected HEK293 cells. These results are consistent with our in vivo data where sortilin knockout mice showed a decrease
of APP lysosomal distribution and an increase of APP in lipid rafts. We further confirmed that overexpression of sortilin-
FLVHRY mutants failed to rescue the lysosomal degradation of APP. Thus, our data suggests that sortilin is implicated in APP
lysosomal and lipid raft targeting via its carboxyl-terminal F/YXXXXF/Y motif. Our study provides new molecular insights
into APP trafficking and processing.
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Introduction
Amyloid precursor protein (APP) contributes to the production
of beta-amyloid (Ab), which is a major component of senile
plaques in the brain of Alzheimer’s disease (AD) patients [1,2].
The processing of APP to Ab involves numerous steps, including
APP sorting, transport, internalization and sequential proteolysis
[3,4]. Newly synthesized APP in endoplasmic reticulum (ER) is
sorted through the trans-Golgi-network (TGN), trafficked to the
cell surface membrane [5], and internalized via its NPTY motif
near the C terminus of APP into endosome/TGN for recycling or
into lysosome for degradation [6], [7]. Ab is generated by b- and
c-secretase sequential cleavage of APP in subcellular compart-
ments [8]. Altered routing of APP trafficking and distribution in
neurons might lead to the amyloidogenic pathway, which is
implicated in the pathology of AD. Hence, the intracellular
distribution and transport of APP are critical for Ab production.
Although several APP binding factors have been reported, for
example, Huntingtin and kinesin light chain are involved in APP
axonal transport in neurons [9], [10,11], the exact mechanism of
APP intracellular trafficking and distribution remains unclear.
Sortilin is important in neuronal functions [12] and shares
genetic similarity with other Vps10p family members, such as
SorLA, SORCS1 and SORCS2 [13]. Its extracellular domain
(ECD) contains a homologous sequence to yeast vacuolar protein
sorting 10 protein (Vps10p) [14]. The intracellular domain (ICD)
is involved in protein internalization and sorting [12,13]. Three
motifs, F/YXXXXF/Y, YSVL and HDDSDEDLLE (dileucine
motif), have been identified in ICD [15]. They might mediate
protein sorting, trafficking and internalization through binding to
adaptor proteins, such as AP-1, AP-2 and GGA [16]. Since not all
of these motifs are present in SorLA, SORCS1 and SORCS2
[17,18], it raises the possibility that sortilin may have diverse
functions in cellular events. This is also backed by evidence that
SorLA is down-regulated [19] but sortilin is up-regulated in AD
[20]. SorLA is reported to retain APP in Golgi, this can lead to
decreasing Ab production. Given that SorLA and sortilin are
members of the same family, the question is if up-regulation of
sortilin might act as a compensation mechanism for the down-
regulation of SorLA in AD. Moreover, lack of sortilin-ICD
prevents sorting of acid sphingomyelinase (ASM) to lysosomes
[21]. In addition, sortilin interacts with HAP1, a protein
facilitating axonal trafficking of the precursor of neurotrophin
[22]. Taken together, these studies suggest that sortilin may be
involved in APP trafficking and processing. Hence, it is important
to further determine how sortilin affects APP trafficking and
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All procedures involving animals were approved by the Animal
Welfare Committee of Flinders University (Ethics No. 703/09)
and the Animal Ethics Committee of SA pathology (Ethics
No. 15b/12), and were undertaken according to the guidelines of
the National Health and Medical Research Council of Australia.
The use of genetically modified animals was approved by the
Biosafety Committee of Flinders University and University of
South Australia. All animals were kept under standardized barrier
breeding conditions with free access to water and food. PCR was
used for genotyping of sortilin knockout mice with 59-TCAG-
GAATGGCATTCTCAG-39/59-AGTGCTGTCTCCAACC-
CAGGAC-39 for wild type and 59- CTCAGGAATGGCATTCT-
CAG-39/59- AAGTCGTGCTGCTTCATGTG-39 primers for
knockout animals.
Cell Culture
Human embryonic kidney 293 cells (HEK293) were obtained
from the American Type Culture Collection (ATCC; Rockville,
MD) and maintained in DMEM medium (Invitrogen) supple-
mented with 10% fetal bovine serum (FBS) and 2 mM glutamine.
Mouse cortical neurons were prepared and cultured as described
[22].
Plasmid Constructs
The constructs of sortilin–CFP were made by PCR, amplifying
Xho1 or EcoR1-BamH1 fragments with the primers 59-
GTCTCGAGCCACCATGGCGCCGGGCGAGGACGAGG-
39/59- TTGGATCCTCCARGAGGTCCTCRTCTG-39 or 59-
GTCTCGAGCCTTCCCCCACAGACATATTTC-39 or 59-
GTCTCGAGGACAATGCCTCGATCATCTGAG-39 for Sort





GAGGTCCTCRTCTG-39 for Sort756–831; 59-
TCGAATTCGCCACCATGAAGAAA-
TATGTCTGTGGGGGA-39/59-TTGGATCCTCCAR-
GAGGTCCTCRTCTG-39 for Sort779–831 from human sortilin
pcDNA3.1-myc/His and cloning into pECFP-N1 (Clontech). To
construct sort del.MS2, sort del.MS1, sort del-MS1/MS2 and sort
MS1/MS2 CFP plasmids, PCR and overlapping PCR were
performed, amplifying theEcoR1-BamH1orEcoR1 fragmentswith
the primers 59- TTGAATTCGCCACCATGGTTCCAAT-
TATCCTGGCCATC-39/59- CTGTGGATCCTGATAAC-













Sort MS1/MS2, and cloning into pECFP-N1. The constructs of
APP-YFP were derived by cloning PCR products generated from
human APP770-YFP pcDNA3.1 with the primers 59-
GCGCCTCGAGGCCACCATGCTGCCCGGTTTGG-
CACTG-39/59- GCGCGAATTCG ATTCATGCGCTCA-
TAAATCAC-39 or 59- GCGCGAATTCG AACCACCTCTTC-
CACAGACTC -39 or 59-
GCGCGAATTCGAACATCCATCCTCTCCTGGTG-39 for
APP 1-542, APP 1-287 and APP 1-141; 59- GCGCCTCGAGGC-
CACCATGGATGTTTGCGAAACTCATC-39/59-
GCGCGAATTCGAACCACCTCTTCCACAGACTC-39 for
APP 141-287; 59- GCGCCTCGAGGCCACCATGAAT-
CAGTCTCTCTCCCTG -39/59- TGGGAATTCG CATCTT-
CACTTCAGAGATCTC-39 for APP 547-671; and 59-
TGGCTCGAGGCCACCATGACAGTGATCGTCAT-
CACCTTG-39/59- TGGGAATTCGGTTCTGCATCTGCT-
CAAAG-39 for APP 713-770, in the Xho1 and EcoR1 sites of
pEYFP-N1. The integrity of all constructs was determined by
sequencing. APP770-YFP pcDNA3.1 andAPP695 pcDNA3.1 were
gifts fromProf.Goldstein (UCSD)andDr.Ma (SoochowUniversity),
respectively. P75CFP-YFP pcDNA3.1 was a gift from Prof. Coulson
(TheUniversity ofQueensland,Australia). SortilinpcDNA3.1-myc/
His (full-length) and Sortilin-T (deleting intracellular domain)
pcDNA3.1-myc/His plasmids were gifts from Dr. Morales (McGill
University).
Immunocytochemistry (ICC) and Colocalization
Antibodies: mouse monoclonal APP antibody (22c11) was
purchased from Millipore. EEA1 (early endosome marker),
mannose 6 phosphate receptor (late endosome marker), Giantin
(Golgi complex marker), and Lamp1 (lysosome marker) antibodies
were purchased from Abcam (Cambridge, USA). Sortilin antibody
(rabbit, OSC-203) was purchased from Osenses (Australia). Mouse
monoclonal Ab antibodies (6E10 and 4G8), Flotillin-1 (lipid raft
marker) antibody and all fluorescent conjugated secondary
antibodies were purchased from Sigma. Cortical neurons prepared
from neonates were used for ICC as described [22]. For
colocalization analysis, Leica SP5 confocal microscopy was used
with a 63/1.4 NA oil immersion lens. Images of fluorochromes
(Cy3/Alexa488/DAPI or YFP/Cy5/CFP) were obtained sequen-
tially using Leica SP5 colocalization model. Quantitative assess-
ment of colocalization between Cy3 and Alexa 488 or YFP and
Cy5 fluorescence signals was performed by calculating the overlap
coefficient (ranging from 0%, minimum colocalization, to 100%,
maximum colocalization), using the Leica Application Suite
software. An average of 20 cells was analysed in each experiment
(three preparations/experiment), and the overlap coefficient (%)
was calculated.
Transfection
Transfection of HEK293 cells was performed as described [22].
Transfection with YFP or CFP constructs served to monitor
transfection efficiency. The percentage of fluorescent cells was
calculated using IX71 microscopy and subjected to normalization.
FRET Acceptor Bleaching (FRET)
FRET was performed as described [22]. The p75CFP-YFP was
used as positive control. A pair of proteins such as APP-YFP and
pECFP (or BDNF-CFP) which show no interaction was used as a
negative control. Each value of FRET eff from the tested samples
including positive, negative and background controls were
determined according to a mean of six individual tests from
different viewing fields. The results were summarized from three
Sortilin Regulates APP Trafficking and Processing
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different experiments. To evaluate the FRET data, the FRETeff
result from the negative control was used as a cut-off in this study.
Coimmunoprecipitation (co-IP) and Western Blot (WB)
Co-IP and WB were performed as described [22]. Briefly, Co-
transfected HEK293 cells were prepared in radio immunoprecip-
itation assay (RIPA) buffer containing 2 mM PMSF and protease
inhibitors (Roche) for cell lysates. The protein concentration of the
lysates was determined using BCA protein assay Kit (Thermo
Scientific, Rockford, USA). Lysates (250 mg) were precleared by
incubation with protein G bead at 4uC for 1 hour and then
incubated with protein G bead-immobilized antibodies at 4uC
overnight. The beads were washed five times and boiled in loading
buffer for WB. Protein G beads bound with rabbit or mouse IgG
and CFP or YFP were used as negative controls. For WB, lysate
proteins (50 mg) were analysed by 10% SDS-PAGE and
transferred to nitrocellulose membrane (GE). Corresponding
primary antibodies (1:1000) were incubated with blots at 4uC
overnight. Horseradish peroxidase-conjugated (HRP) secondary
antibodies (1:2000) were used for detection. b-Actin was used as a
loading control. Imaging was performed using ECL (GE). ImageJ
(NIH) was used for quantitative analysis.
Lipid Raft Fractionation
Lipid rafts were prepared from transfected HEK293 cells in two
10 cm culture dishes and mouse brains as described previously
[23,24] with some modifications. Briefly, transfected cells or mouse
brain were resuspended in 0.5 ml of lysis buffer containing 50 mM
tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1 mM PMSF,
and 0.5% Triton X-100 supplemented with Complete protease
inhibitor cocktail (Roche). Cells or brain tissue were homogenized
by passages through a 25-gauge needle seven times. The
concentration of total protein was measured by the Bio-Rad
protein assay kit II (Bio-Rad). A total of 4 mg of protein from the
Figure 1. Sortilin and APP are allied in vitro and in vivo. (A) Colocalization of sortilin and APP. Mouse cortical neuron (upper) and brain cortex
(lower) were immunostained for APP (red) and sortilin (green). Colocalization of sortilin and APP was indicated in merged panels (yellow). DAPI
stained cell nuclei (blue). Plotted colocalization: 92% mean6 SEM, n = 20, in cortical neurons and 95% mean6 SEM, n = 3, in brain cortexes. Scale bar
25 mm for cortical neurons, 5 mm for enlarged image and 100 mm for brain cortex. (B) Co-IP of sortilin with APP in co-transfected HEK293 cells.
HEK293 cells growing in 10 cm culture dishes were co-transfected with APP770-YFP/Sort-FL-myc/His (lane 1, 4) or Sort-T-myc/His (lane 2, 5). Cell
lysates were immunoprecipitated with rabbit anti-GFP (a-GFP) for APP and blotted with mouse anti-Myc (a-Myc) for sortilin. Mixed lysates were used
for IgG (lane 3). Sort-FL-myc.His (Sort-myc), Sort-T-myc.His (sort-T-myc) and APP770-YFP (APP-YFP) are indicated by arrows. (C) Co-IP of sortilin with
APP in APPSwe/PS1dE9 transgenic mouse brain lysate. Mouse brain lysates were subjected to immunoprecipitation with rabbit anti-APP C’ (a-APP C’)
and blotted with rabbit anti-sortilin (a-Sort) (left panel) or immunoprecipitation with a-Sort and blotted with a-APP C’ (right panel). Sortilin and APP
are indicated by arrows. (D) Control for Co-IP using pEYFP. HEK293 cells were co-transfected with pEYFP/Sort-myc. Co-IP was performed using a-GFP
and blotted with a-sort and a-GFP. Rabbit IgG (IgG) was used as a control for non-specific binding.
doi:10.1371/journal.pone.0063049.g001
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homogenates was mixed with lysis buffer containing sucrose to
yield a final concentration of 45% sucrose in 1 ml and laid at the
bottom of an ultracentrifuge tube. To form a discontinuous
sucrose gradient, Lysis buffer containing 35% (2 ml) and 5%
(2 ml) sucrose were sequentially laid over the homogenates. The
samples were ultracentrifuged at 44,000 rpm in a Beckman SW55
rotor at 4uC for 17 hours. Ten 0.5 ml fractions were collected
from top to bottom of the gradient sample. Equal volumes (15 ml)
of each fraction were subjected to SDS-PAGE for WB.
Statistical Analysis
All statistical analyses were performed with SPSS software
(version 19.0). Data were expressed as means 6 SEM and p,0.05
was considered significant. Variables between groups were
determined by independent t-test or ANOVA.
Results
Sortilin is Associated with APP in vitro and in vivo
To investigate if sortilin is involved in APP processing, we first
determined whether endogenous APP colocalized with sortilin in
primary cortical neurons. Double-labelling of cortical neurons and
frozen cerebral cortex sections showed colocalized APP and
sortilin as punctual distribution in perinuclear region and axons.
Approximately 92% and 95% of APP was highly colocalized with
sortilin in either cortical neurons or cerebral cortex, respectively
(Fig. 1A), suggesting an interaction between sortilin and APP. To
further test this hypothesis, we performed co-IP using HEK293
cells co-expressing APP/full-length sortilin-myc/His (Sort-FL) or
APP/sortilin-T-myc/His (Sort-T, a truncated form lacking the
intracellular domain). Our results showed that both Sort-FL and
Sort-T were immunoprecipitated by APP770-YFP, with rabbit
anti-GFP antibody but did not show in negative controls
immunoprecipitated with either rabbit IgG (Fig. 1B) or pEYFP
(Fig. 1D). Sortilin and APP from brain homogenates of APPSwe/
PS1dE9 transgenic mice (Jackson Laboratory) were also detected
in the APP or sortilin immunoprecipitated complexes, but not
found in the negative control (rabbit IgG) (Fig. 1C). Therefore, the
interaction between sortilin and APP is present either in vitro or
in vivo, suggesting that the interaction may have significant
influence on cellular sortilin/APP events.
Determining Sortilin and APP Binding Sites
To further characterize the interaction between sortilin and
APP, we constructed sortilin and APP clones harbouring varied
regions in pECFP-N1 and pEYFP-N1 vectors for FRET, co-IP
and cellular studies according to taxonomic and functional
structures. Since mature sortilin receptor, a bioactive form, is
released by furin cleavage from its proform at amino acid (aa)
residue 77 in neurons [15], we selected the mature region (78–831
aa) for cloning. Due to lacking the signal peptide and/or
transmembrane domain (TMD) in some constructs, they might
express a misfolded form to some extent, which could interfere
with protein-protein interaction and protein function. To deter-
mine if constructs contain a misfolding, we performed the N-
terminal fusion to CFP or YFP so that protein misfolding would
Figure 2. A schematic diagram of APP-YFP and sortilin-CFP constructs. The region of 78–831 aa is chosen for cloning based on that mature
sortilin receptor, a bioactive form is released by furin cleavage from its proform at amino acid (aa) residue 77 in neurons (see results). The region
cloned into pEYFP-N1 or pECFP-N1 is indicated by open and solid boxes. The line indicates the deleted region. Abbreviation: signal peptides: SP;
extracellular domain: ECD; transmembrane domain: TMD; intracellular domain: ICD; amino acid: aa; gamma secretase: c-Sec; furin cleavage site: FS;
Motif 1: MS1 (787FLVHRY792); Motif 2: MS2 (823HDDSDEDLL831); deletion: del.; Arrowhead: a or b secretase cleavage site.
doi:10.1371/journal.pone.0063049.g002
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result in a loss of fluorescence [25]. We found all APP and sortilin
constructs showed a bright fluorescence in transfected HEK293
cells, and sortilin constructs such as Sort 78–831 and Sort 756–831
represented an intracellular distribution similar to Sortilin-FL
(data not shown), suggesting that these constructs rarely have a
protein misfolding and incorrect sorting. Thus, these constructs
were used for this study. The schematic diagrams depicting the
constructs were shown in Figure 2A and 2B.
To identify the binding sites between sortilin and APP, we
performed a FRET using HEK293 cells coexpressing APP770-
YFP and sortilin-CFP proteins. Three sortilin-CFP DNA con-
structs, named Sort 78–831 (containing the mature region of
sortilin), Sort 78–786 (by removing the entire intracellular domain
(ICD) except the first N-terminal 7 amino acids of the ICD) and
Sort 756–831(comprising the transmembrane domain (TM) and
ICD) were co-transfected with APP770-YFP into HEK293 cells,
respectively (Fig. 3). Although all three sortilin CFP constructs
together with APP770-YFP were expressed in HEK293 cells in a
similar manner, the significant FRET efficiency (FRETeff) gener-
ated by these constructs from high to low is Sort 756–831(40%
FRETeff), Sort 78–831(25% FRETeff) and Sort 78–786 (15%
FRETeff), compared with negative control (NC). As Sort-T showed
an interaction with APP (Fig. 1B), the less efficient binding of the
N-terminus (78–786 aa) of sortilin to APP is unlikely due to the
first seven amino acids of ICD overlapping between Sort 78–786
and Sort 756–831 and/or an alteration of the C-terminal binding
site. Thus, this data suggests that both N- and C-termini of sortilin
may interact with APP, but that the C-terminus has much stronger
interaction than the N-terminus.
Given the results that both sortilin-ICD and ECD interact with
APP, we subsequenty narrowed down the sortilin binding sites to
APP by co-IP. We found that Sort 78–385, Sort 756–831, and
Sort 779–831 were present in the samples immunoprecipitated
with APP antibody (22c11) but not Sort 385–786 which contains
the C’-terminal portion of the Vps10p domain (Fig. 4A). No
specific band was found when non-specific immunoglobulin
(mouse IgG) was used for co-IP, and APP was confirmed in all
co-IP samples (Fig. 4A). These results confirmed that sortilin has
two binding sites to APP, one in ECD within 78–385 (N’-terminal
part of the VPS10 domain) and the other in ICD. We further
characterized the binding site of sortilin-ICD to APP and found
that Sort-del.MS2 and Sort-MS1/MS2 were coimmunoprecipi-
tated with 22c11, whereas Sort-del.MS1 and Sort-del.MS1/MS2
were not detected using the same antibody (Fig. 4B). In negative
controls, neither the mouse IgG pulled down any specific band nor
the anti-APP antibody immunoprecipitated pECFP from HEK293
cells co-expressing APP695 and pECFP (Fig. 4C). Thus, our data
indicates that while the deletion of MS2 alone did not affect
sortilin-ICD binding to APP, the deletion of MS1 however,
completely abolished the interaction of sortilin-ICD with APP,
suggesting that MS1 is a key binding site to APP.
In order to further validate the interaction between sortilin and
APP, we performed the competitive co-IP assay using synthesized
MS1 peptide or purified Sort-T-myc/His protein as the control
competition in co-IP reaction. We monitored if the MS1 peptide
and Sort-T effectively compete with the protein interaction. We
found that Sort-T blocked Sort 78-385 binding to APP695, but not
by BSA; and the MS1 peptide blocked Sort del.MS2 binding to
APP695, but not by scramble MS1 peptide (Fig. 4D). Both BSA
and scramble MS1 peptide were used as non-specific binding
controls in the competitive co-IP. In addition, we made two new
constructs, Sort-sp-78-385 and Sort-sp-del.MS2, which are similar
to Sort-78-385CFP and Sort-del.MS2CFP but also includes a
signal peptide. We used these constructs for the competitive co-IP
and found the results were similar to when we used the constructs
without a signal peptide, suggesting that these original constructs
were not misfolded (Fig. 4E).
To determine which part of APP binds to sortilin, we performed
co-IP in a similar way using each APP construct and Sort-FL. We
found that APP 1-287, APP 1-542 and APP 713-770 were detected
in the samples immunoprecipitated with anti-myc antibody but
not APP 541-671 (Fig. 5A). However, only APP 1-287 and APP 1-
542 were immunoprecipitated with Sort-T (Fig. 5A). The
specificity of Co-IP was confirmed by using pEYFP, which
showed Sort-FL did not interact with pEYFP (Fig. 1D). In
addition, Sort-FL or Sort-T was detected in the co-IP samples
(Fig. 5A). Taken together, the data demonstrate the intermolecular
head-to-head and tail-to-tail interactions between sortilin and
APP, and suggest that APP 1-287 and APP 713-770 interact with
Sort 78-385 and Sortilin MS1, respectively. Indeed, we found that
Sort 78-385 was immunoprecipitated with APP 1-287 by anti-APP
N’ terminal antibody (Fig. 5B) and that Sort del.MS2 was
immunoprecipitated with APP 713-770 by anti-APP C’ terminal
antibody (Fig. 5D), whereas no specific band was shown when
mouse and rabbit IgG as non-specific binding was used for co-IP.
To further narrow down N’ terminal APP binding site to sortilin,
two APP constructs, APP 1-141 and APP 141-287, were cloned
and used for co-IP. It was determined that APP 1-141 was
coimmunoprecipitated with sortilin-myc/His (sort-FL) by anti-myc
Figure 3. FRET analysis of the interaction between sortilin and
APP. HEK293 cells co-transfected with APP770-YFP (APP-YFP) and
different sortilin-CFP constructs were used for FRET. (A) FRET efficiency
representing the protein-protein interaction was determined from a
photobleached region of interest (ROI). (B) Expression levels for
constructs used in FRET were determined by Western blot with gt-a-
GFP. b-Actin was blotted with mouse-a-actin for sample equal loading.
NC: negative control. PC: positive control. Three independent experi-
ments were performed. Bars represent mean6SEM (n= 6 ROI63). The
star (*) indicates p,0.01.
doi:10.1371/journal.pone.0063049.g003
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antibody (Fig. 5C left panel) but not APP 141-287 (data not
shown). Similar data resulted when using anti-GFP antibody for
co-IP, which showed Sort-FL was coimmunoprecipitated with
APP 1-141 (Fig. 5C right panel) but not with APP 141-278 (data
not shown). Thus, our data indicate that APP 1-141 contained a
binding site to sortilin 78-385.
In addition, our FRET data also showed that substitution of
tyrosine (Y) and the last phenylalanine (F) with alanine (A) in
NPTYKFFE motif (NPTY overlapping with YKFFE), of APP-
ICD completely abolished the interaction between Sort-del.MS2
and APP 713-770, suggesting that the NPTYKFFE motif is
important for APP-ICD to interact with sortilin MS1 (Fig. 5E).
NPXpY within NPTYKFFE is an internalization signal for
membrane proteins [26] and is involved in the interaction of
several cytoplasmic proteins [27].
Sortilin Regulates APP into Late Endosomes/Lysosomes
To analyse the APP intracellular distribution in more detail, we
double-labelled WT and sortilin KO mouse cortical neurons with
specific antibody to APP and to different cellular compartments
(Fig. 6). We found that a small fraction of APP colocalized with
Golgi complex in both WT (28%) and KO (17%) in cells. Also, a
small amount of APP colocalized with early endosome marker
Figure 4. Mapping sortilin binding to APP. (A) Identifying sortilin binding sites to APP. HEK293 cells were co-transfected with APP695-pcDNA3.1
(APP695) and Sort 78–385-CFP (lane 1) or Sort 385–786-CFP (lane 2), or Sort 756–831 (lane 3), or Sort 779–831-CFP (lane 4). Cell lysates were
immunoprecipitated with mouse anti-APP, 22c11, (a-APP, lanes 1–4) and mouse IgG (mixed lysates, lane 5), and blotted with goat-anti-GFP (gt-a-
GFP). Lysates were used as input (lanes 6–9). Sort 78–385CFP (61 kDa), Sort 385–786CFP (71 kDa), Sort 756–831CFP (35 kDa) Sort 779–831-CFP
(32 kDa), APP695 (100 kDa) and IgG heavy chain (HC, 50 kDa) are indicated by arrows. (B) Determining sortilin C-terminal FLVHR motif (MS1) binding
to APP. APP695 was used with Sort del.MS2-CFP (lanes 1, 6) or Sort del.MS1-CFP (lanes 2, 7) or Sort del.MS1/MS2-CFP (lanes 3, 8) or Sort MS1/MS2
(lanes 4, 9) for co-transfection. Co-IP was performed as (A). Sort del.MS2-CFP (34 kDa), Sort del.MS1-CFP (34 kDa), Sort-del.MS1/MS2-CFP (32 kDa),
Sort MS1/MS2-CFP (33 kDa) and APP695 in precipitated samples and lysate are indicated by arrows. (C) Control for Co-IP using pECFP. HEK293 cells
were co-transfected with pECFP/APP695. Co-IP was performed using a-APP and mouse IgG (IgG) as indicated. The blot was probed with a-GFP
(upper) and re-probed with a-APP (lower). Lysate was used as input. APP695 and CFP (27 kDa) are indicated by arrows. Mouse IgG was used as a
control for non-specific binding in all co-IP. (D and E) Sort-T-myc/His and MS1 peptide (CGGRFLVHRYSVLQQ; Peptide-2.0, Chantilly, VA)
corresponding to the amino acids 783–797 of sortilin (GenBank Accession No. NM_002959) prevent sortilin N or C terminal constructs binding to APP
in the competition binding assay, respectively. Sort-78–385CFP and Sort-del.MS2CFP (D) and two new sortilin constructs (termed Sort-sp-78–385-CFP
and Sort-sp-del.MS2CFP) created by overlapping PCR and cloned in pECFP (E) were used in the competition binding assays. The integrity of the
constructs was confirmed by DNA sequencing. To purify Sort-T-myc/His, HEK293 cells growing in 3610 cm culture dishes were transfected with Sort-
T-myc/His for 48 h. Cells were harvested in cold PBS containing 1 mM PMSF and protease inhibitor (Roche), sonicated on ice and centrifuged at
15000 rpm at 4uC for 10 minutes. The supernatant was loaded into Ni-NTA column (Qiagen) and eluted in elution buffer after washing. The elute
protein was concentrated by Amicon Ultra- Centrifugal Filters (Millipore) and the protein was recovered in 50 ml of PBS pH 8, containing 1 mM PMSF
and protease inhibitor. For competition binding assays, HEK293 cells (1610 cm dish) were transfected with APP695 or each sortilin construct for 48
hours and harvested for preparing cell lysates. The lysate containing APP695 was incubated with 50 ml (+) of the purified Sort-T-myc/His protein or
with 10 mM (+) of MS1 peptide at 4uC for 1 hour and then combined with the lysate containing Sort-78-385CFP or Sort-del.MS2CFP or Sort-sp-78-385-
CFP or Sort-sp-del.MS2-CFP, and the incubation was continued for 2 hours at 4uC with rotation. The lysates were then immunoprecipitated with a-
APP and blotted for Sort-78-385 and Sort-del.MS2 by gt-a-GFP, respectively. Cell lysate was used as input. Scramble MS1 peptide (Scramble, 10 mM)
and BSA (10 mM) were used as control for non-specific competition. Sortilin constructs and APP695 from co-IP samples and inputs are indicated by
arrows.
doi:10.1371/journal.pone.0063049.g004
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(EEA1) in WT neurons (4%) and KO neurons (12%). Interest-
ingly, a high proportion of APP was found to colocalize with late
endosome marker (78%) in WT neurons, but the colocalization
was significantly decreased to 60% in sortilin KO neurons
(p,0.05). Moreover, 82% of APP was found to colocalize with
lysosome marker in WT neurons, whereas the colocalization was
significantly decreased to 63% in sortilin KO neurons (p,0.05). A
significant decrease of colocalization of APP in late endosomes and
lysosomes in sortilin KO neurons relative to WT neurons was
further confirmed after the data was plotted quantitatively (Fig. 6).
This data suggests that sortilin is involved in trafficking of APP in
the endosome-lysosome pathway. Also, the colocalization between
APP and Golgi complex was significantly higher in WT than KO.
There was a noticeable change in terms of the colocalization of
APP with EEA1 in both WT and KO neurons, but the detected
change was too low to be informative for this study.
Figure 5. Mapping APP binding to sortilin and the binding sequences. (A) Determining APP 1-287 and APP 713-770 binding to sortilin.
HEK293 cells were co-transfected with sort-FL-myc and APP 1-287YFP or APP 1-542YFP or APP 541-671YFP or APP713-770YFP (lanes 1–4). Sort-T-myc
was used for the co-transfection with the same APP-YFP constructs (lanes 5–8). Lysates from each co-transfection were used as input (lane 9–12). Cell
lysates immunoprecipitated with a-Myc (lanes 1–8) and inputs were blotted with goat (gt)-a-GFP. The co-IP blot was re-probed with a-Myc for sortilin
constructs (lower). APP 1-542YFP (87 kDa), APP 1-287YFP (58 kDa), APP 541-671YFP (42 kDa), APP 713-770YFP (33 kDa), Sort-myc (115 kDa) and Sort-
T-myc (110 kDa) are indicated by arrows. (B) Determining N terminal binding sites between APP and sortilin. HEK293 cells were co-transfected with
APP 1-287YFP and Sort 78-385CFP. Cell lysates were immunoprecipitated with a-APP-N’ for APP1-287YFP (lane 1) and mouse IgG (mIgG) as a control
for non-specific binding (lane 2), and blotted with gt-a-GFP. Lysate was used as input (lane 3). APP1-287YFP (58 kDa) and Sort78-385CFP (61 kda) are
indicated by arrows. (C) Determining APP 1-141 binding to sortilin. HEK293 cells were co-transfected with APP 1-141YFP and Sort-FL-myc. Cell lysates
were immunoprecipitated with a-Myc for Sort-FL-myc (lane 1) and mIgG (lane 2), and blotted with gt-a-GFP for APP1-141YFP. The direct
Immunoprecipitated APP1-141YFP by a-GFP was used as input (lane 3). Also, cell lysates were immunoprecipitated with rabbit-a-GFP for APP1-
141YFP (lane 4) and rabbite IgG (rIgG) as control (lane 5), and blotted with a-Myc for sortilin. The direct immunoprecipitated Sort-FL-myc by a-Myc
was used as input (lane 6). APP1-141YFP (41 kDa) and Sort-FL-myc (115 kDa) are indicated by arrows. (D) Determining C terminal binding sites
between APP and sortilin. HEK293 cells were co-transfected with APP 713-770YFP and Sort del.MS2-CFP. Cell lysates were immunoprecipitated with
a-APP-C’ for APP 713-770YFP (lane 1) and rIgG (lane 3), and blotted with a-Sort C’. Lysate was used as input (lane 2). Sort del.MS2-CFP (34 kDa) is
indicated by arrow. (E) Determining Sort-MS1 (del.MS2) interaction with APP NPTYKFFE motif. Sort del.MS2-CFP was used with APP 713-770-YFP or
APP 713-770 mut-YFP for the co-transfection of HEK293 and then subjected to FRET. APP 713-770 mut-YFP construct contains a mutated NPTYKFFE
motif where Y and F (underlined) are substituted with A. FRET efficiency representing the protein-protein interaction was determined from a
photobleached region of interest (ROI). Three independent experiments were performed. Bars represent mean6 SEM (n= 6 ROI63). The star (*)
indicates p,0.01. Abbreviation: negative control: NC; positive control: PC.
doi:10.1371/journal.pone.0063049.g005
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Sortilin Regulates APP into Lipid Rafts
To further determine if APP is possibly exposed to b- and c-
secretase in the presence or absence of sortilin, we investigated
APP distribution in lipid rafts that involve high b and c-secretase
activities, Ab production and aggregation [23,28,29]. We
performed double-labelling of mouse cortical neurons with
antibodies to APP and flotillin-1, a lipid raft component, and
analyzed the colocalization of APP with lipid rafts by counting the
number of merged spots in neurons. We found that sortilin KO
neurons displayed a 2-fold increase in colocalization, over WT
neurons (p,0.01), suggesting that APP is more likely to be
associated with lipid rafts after deletion of sortilin (Fig. 7).
Deletion of Sortilin MS1 Reduces APP Distribution in
Lysosomes
As sortilin ICD showed a strong interaction with APP, we
focused on characterising this binding site. To determine if the
identified binding site of sortilin-ICD to APP influences APP
lysosomal trafficking, we performed ICC using HEK293 cells co-
expressing APP770-YFP and each varied sortilin-ICD construct
(e.g., Sort del.MS2, Sort del.MS1/MS2 and Sort-FL). To avoid
fluorescent dye (YFP and CFP) interfering, lysosomes was stained
by Cy5. Our results showed Sort-FL and Sort del.MS2 yielded a
cytoplasmic distribution of APP, whereas Sort del.MS1/MS2
caused APP aggregates in the preinuclear regions. Cells co-
expressing pECFP showed a cytoplasmic distribution of APP
similar to Sort-FL and Sort.del.MS2, suggesting that the
expression of CFP (mock DNA) did not affect APP cellular
distribution but Sort del.MS1/MS2 did. We also observed that
high colocalization of APP with lysosome resulted from Sort-FL
(70%), Sort del.MS2 (75%) and CFP (72%), whereas low
colocalization of APP with lysosome was shown by Sort
del.MS1/MS2 (55%) (Fig. 8A). The colocalization of APP with
lysosome was significantly altered in the cells expressing Sort
del.MS1/MS2, compared with Sort-FL or Sort del.MS2 (p,0.01).
The question is if the formation of aggregates of APP in the
cytoplasm, after transfecting the cells with Sort del.MS1/MS2
would or would not result in a general failure of the sorting
process. To address this question, we examined the endogenous
lysosomal trafficking of acid sphingomyelinase (ASM) [21] in
HEK293 cells transfected with Sort-FL, Sort del.MS1 and pECFP,
respectively. Our data indicated that Sort del.MS1 did not have a
significant impact on the endogenous ASM trafficking to
lysosomes, compared with Sort-FL (Fig. 8B), suggesting the sorting
process was not altered in the transfected cells. Therefore, lack of
MS1/MS2, especially the deletion of MS1 might impair APP
lysosome trafficking and intracellular distribution.
Deletion of MS1 or Sortilin Increases APP Distribution in
Lipid Rafts
To further investigate if the binding site of sortilin-ICD to APP
affects the distribution of APP in lipid rafts, we performed lipid raft
fractionation using HEK293 cells co-transfected with APP695 and
different sortilin constructs. We found that APP was detected in
low density lipid raft fractions (3–6) in cells transfected with Sort-
del.MS1 or pECFP (mock DNA), whereas APP was retained in
high density fractions (8–10) in cells transfected with Sort 756-831
or Sort-FL (Fig. 9A). APP in lipid rafts was significantly increased
in Sort-del.MS1 transfections, compared with Sort 756-831 and
Sort-FL (p,0.01), suggesting that the deletion of sortilin MS1 can
result in an increase of APP in lipid rafts, probably due to the
redistribution of APP from high density fractions to lipid raft
fractions. APP redistribution in mock DNA transfections may be
Figure 6. Lack of sortilin reduces APP distribution in lysosome
and increases APP distribution in lipid rafts. Colocalization of APP
with cell organelles in cortical neurons. Wild type (WT) and sortilin
knockout (KO) mouse cortical neurons were immunostained for APP
with mouse anti-APP-N’ (22c11) and followed by staining with Cy3
conjugated secondary antibodies (red) and cell organelles: Golgi, Early
endosome, late endosome and lysosome immunostained with Giantin,
EEA1, anti-mannose 6 phosphate receptor (for late endosome) and
Lamp1, followed by staining with Alexa 488 conjugated secondary
antibodies (green). Cell nuclei are stained by DAPI (blue). The
colocalization is indicated in merged panels (yellow). Snapshots of
colocalization are shown on the right of each panel. The percentage of
colocalization (Col.) is plotted and is represented as mean6 SEM
(n = 20). The colocalization of APP with cell organelles is compared
between WT and KO neurons. The star (*) indicates p,0.01. Scale bar
10 mm.
doi:10.1371/journal.pone.0063049.g006
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due to overexpression of APP relative to sortilin. In vivo lipid raft
fractionation studies also showed a significant increase of APP in
lipid raft fraction (3–4) in the brain tissues of sortilin KO mice,
compared with WT mice (p,0.01), indicating that a lack of sortilin
causes APP redistribution to lipid rafts (Fig. 9B).
Deletion of MS1/MS2 Reduces the Lysosomal
Degradation of APP in Transfected HEK293 Cells
To address if sortilin mediates APP to lysosomes for degrada-
tion, we examined if treatment with the lysosomal inhibitor
bafilomycin A1 (BafA1) could rescue steady-state levels of APP in
cells co-expressing either sort-FL or Sort del.MS1/MS2 [30]. Cells
treated with BafA1 showed a significant increase of steady-state
Figure 7. Lack of sortilin increases APP distribution in lipid rafts in cortical neurons. Wild type (WT) and sortilin knockout (KO) mouse
cortical neurons were immunostained for APP with mouse anti-APP-N’ (22c11) and followed by staining with Cy3 conjugated secondary antibodies
(red), and lipid rafts were immunostained with anti-flotillin, followed by staining with Alexa 488 conjugated secondary antibodies (green). Cell nuclei
are stained by DAPI (blue). Colocalization is analyzed by counting the number of merged APP/raft lipids (yellow), and is plotted as mean of fold
increase 6 SEM (n= 20 neurons). The star (*) indicates p,0.01. Scale bar 7.5 mm.
doi:10.1371/journal.pone.0063049.g007
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levels of APP in the absence of sortilin, consistent with previous
reports that APP proteins are targeted for lysosomal degradation
[6,31,32] (Fig. 10). Co-expression of Sort-FL yielded a significant
decrease in steady state levels of APP, whereas co-expression of
Sort-del. MS1/MS2 did not show any significant change of APP
levels in untreated cells, compared with untreated controls
(pcDNA). The expression of APP levels was significantly rescued
by adding BafA1 to inhibit lysosomal activities (Fig. 10) (p,0.01).
This data suggests that sortilin can transport APP to lysosomes for
degradation and that MS1 and MS2 may play an important role
in this process.
Discussion
APP is well known for its cleaved products (Ab, CTF and
AICD), which are implicated in the pathogenesis of AD. Although
the function of APP remains to be fully elucidated, understanding
APP trafficking and processing would provide new insights into the
regulatory mechanism of the amyloidogenic pathway. In this
study, we investigated the role of sortilin in APP trafficking and
distribution, and the underlying molecular mechanisms. We found
that 1) sortilin is associated with APP via head-to-head (the
extracellular domain) and tail-to-tail (the intracellular domain)
interactions; and 2) sortilin regulates APP lysosomal and lipid raft
trafficking through FLVHRY motif.
Figure 8. Effect of sortilin binding domain on APP lysosomal targeting. A: APP colocalization with lysosome. HEK293 cells were co-
transfected with APP770-YFP and different sortilin constructs. The expressed APP and sortilin constructs excluding Sort-FL were visualized by either
YFP or CFP fluorescence. Sort-FL-myc/His was immunostained with anti-sortilin, followed by staining with Cy3 conjugated secondary antibodies.
Lysosomes were immunostained with lysosomal antibody (Lamp1), followed by staining with Cy5 conjugated secondary antibodies. B: Sortilin
constructs sorting ASM to lysosomes. HEK293 cells were transfected with different sortilin constructs. The endogenous ASM was immunostained with
mouse anti-ASM (Abcam), followed by staining with Cy3 conjugated secondary antibodies. Lysosome were immunostained with lysosomal antibody
(Lamp1), followed by staining with Alexa 488 conjugated secondary antibodies. Sortilin constructs excluding Sort-FL were visualized by CFP
fluorescence. Sort-FL-myc/His was immunostained with anti-sortilin, followed by staining with Cy5 conjugated secondary antibodies. Plotted
colocalization is indicated at bottom. The percentage of colocalization is represented as mean6 SEM (n= 20). The colocalization is compared with
Sort-FL. The star (*) indicates p,0.01. Scale bar 7.5 mm.
doi:10.1371/journal.pone.0063049.g008
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The Interaction between Sortilin and APP is Important for
APP Intracellular Distribution Including Lysosomal
Targeting and the Distribution in Lipid Rafts
Our results show that sortilin is involved in APP intracellular
distribution via the interaction between sortilin and APP. Our
mapping study has defined that sortilin interacts with APP through
each ICD and ECD. The sortilin N-terminal binding site in ECD
to APP is identified within amino acid 78-385, which contains part
of the Vps10p domain. However, the Vps10p domain of SorLA
has shown no interaction with APP [33], suggesting this binding
site is unique to sortilin. Since SorLA has been reported to interact
with APP via the luminal domain [34] and the cytoplasmic tail
[35], it is suggested that sortilin is likely to have a second binding
site to APP. Indeed, we have identified that the sortilin C-terminal
binding site to APP is FLVHRY (MS1) belonging to the F/
YXXXXF/Y motif because the deletion of the FLVHRY
abolishes the interaction between sortilin-ICD and APP-ICD.
Given the fact that the F/YXXXXF/Y motif exists in SorLA and
acts as an internalization/sorting signal in mannose-6 phosphate
and low-density lipoprotein receptors [15], this interaction
between APP and the FLVHRY motif highlights the potentially
important role of sortilin in APP trafficking and processing. This is
further supported by our in vivo and in vitro data which shows an
altered distribution of APP in lysosomes and lipid rafts in neurons
of sortilin KO mice, and in HEK293 cells co-expressing the
sortilin MS1 deletion constructs. The APP-NPXYKFFE motif is
likely to be responsible for the C’-terminal interaction with sortilin
FLVHRY, because mutation of the NPXYKFFE motif eliminates
this interaction. Recent reports have shown that mutant YKFFE
motif (overlap with NPXYKFFE) is associated with redistribution
of intracellular APP [36,37], which could be a result of the
disruption of the interaction between sortilin FLVHRY and APP
NPXYKFFE. It is possible that the sortilin-ICD is involved in
controlling the fate of intracellular APP. Phosphorylation of APP
at T668, located 14 amino acids toward the N-terminal end from
the 681GYENPTY687 motif, has been reported to regulate the
Figure 9. Effect of sortilin on APP distribution in lipid rafts. A: HEK293 cells co-transfected with APP695 and sortilin constructs were lysed in
Triton-X-100 buffer and subjected to discontinuous sucrose density gradient ultracentrifugation fractionation. Equal volumes from each fraction were
examined by WB for APP and flotillin-1. B: Lack of sortilin increases APP distribution within lipid rafts in sortilin KO mice. Mouse brains were
homogenized in Triton-X-100 buffer and subjected to discontinuous sucrose density gradient ultracentrifugation fractionation. Equal volumes from
each fraction were examined by WB for APP and flotillin-1. Bars represent mean6 SEM (n = 3) from three independent experiments. The star (*)
indicates p,0.01.
doi:10.1371/journal.pone.0063049.g009
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interaction of the 681GYENPTY687 motif with other binders [38],
suggesting that the phosphorylation may be involved in the
interaction between sortilin FLVHRY and APP NPXYKFFE.
The NPXYKFFE, containing a core NPXpY element, mediates
APP internalization as well as the interaction between the proteins
bearing phosphotyrosine-binding domains (such as Fe65, Shc,
X11, mDab1 and JIP) [36,39]. There is evidence to suggest that
JIP is associated with the kinesin-1 motor [40,41]. Sortilin also
interacts with HAP1, a protein interacting with the p150glued
subunit of dynactin [41], which regulates neurotrophin axonal
trafficking [22,42]. The interactions between these proteins can
facilitate appropriate APP axonal transport and is important to
sort APP into the non-amyloidgenic pathway [27]. Further studies
are warranted to determine if the phosphorylation of APP at T668
plays a crucial role in the interaction with sortilin FLVHRY and if
the N-terminal binding site of sortilin to APP has any roles in APP
trafficking and processing. Nonetheless, our data indicates that the
head-to-head and tail-to-tail interactions are required for sortilin/
APP cellular events.
Sortilin and its ICD may Play a Role in APP Processing by
Regulating APP Trafficking to Lysosome and Lipid Rafts
The sortilin-ICD, especially the FLVHRY motif, plays an
essential role in APP intracellular trafficking to the appropriate
organelles. We found that a lack of sortilin and co-expression of
sortilin constructs do not affect the distribution of APP in ER (data
not shown), thus sortilin is not required in APP synthesis and APP/
ER exit. However, the loss of sortilin or the deletion of FLVHRY
causes a significant increase of APP in lipid rafts, but a decrease of
APP in lysosome of neurons (Fig. 6, 7, 8A and 9), suggesting that
sortilin can regulate APP into lysosomes and reduce the b and c-
secretase cleavage of APP in lipid rafts. In fact, the effect of sortilin
on protein sorting to lysosomes has been described previously
[6,43]. The lysosomal trafficking of the sphingolipid activator
proteins, b-hexosaminidase and b-glucuronidase is mediated by
sortilin through Golgi-localizing, gadaptin ear homology domain,
ARF-binding proteins adaptor protein (GGA). The cytoplasmic
tail of sortilin also contains a dileucine motif that binds the GGA
[12]. Therefore, it is possible that sortilin can mediate APP
lysosomal targeting in a similar manner. We further demonstrated
that sortilin mediates APP to lysosomes for degradation, where the
FLVHRY (MS1) motif appears to be essential (Fig. 10A). This
motif is responsible for the interaction with APP, but the dileucine
motif may provide molecular bridging and flanking sequences for
context in regulating APP trafficking and processing in cells. In
addition, co-expression of Sort-del.MS1/MS2 is associated with
the formation of APP aggregates in the cytoplasm in the
transfected cells, raising the possibility that this would cause a
general failure of the sorting process. By testing another protein,
ASM known to be sorted to lysosomes by sortilin, we have
demonstrated that the formation of APP aggregates is not the
consequence of the general failure of the sorting process (Fig. 8B).
Similar results have also been reported in TGF-b lysosomal
targeting mediated by sortilin mutant constructs [30].
It is generally believed that SorLA retains APP in TGN, which
has contributed to the non-amyloidogenic pathway [34]. Howev-
er, sortilin may also function to prevent APP into the amyloido-
genic pathway. A lack of the sortilin function would lead to an
abnormal routing of APP trafficking. For example, an increase of
APP distribution was found in lipid rafts in sortilin KO neurons as
oppsed to WT neurons, suggesting the involvement of amyloido-
genic processing of APP [44,45]. Also, high activity of b-secretase
and Ab production have been reported in TGN, cellular
organelles and lipid rafts [8,23,28,46], suggesting sortilin nega-
tively regulates Ab production. Indeed, our results showed that the
deletion of the FLVHRY motif and lack of sortilin caused an
increase of APP in lipid rafts and a decrease of APP in lysosomes
(Fig. 6, 7 and 9), suggesting that sortilin and this motif are more
likely to affect APP processing. We are aware that an increase in
Ab was previously reported in a sortilin stable transfected cell-line
[20]. The explanation of the discrepancy might be accounted for
by a variety of factors, including difference in the experimental
design, cell types and analysis. However, the results from the
deletion of MS1 are in agreement with that reported by the same
group, showing a significant increase in Ab by deleting sortilin
ICD. Our data from the present study has implied that the effect
of sortilin on APP intracellular distribution directly contributes to
maintaining the balance of Ab production, as a false routing and/
or a prolonged exit from Golgi-TGN and/or the cellular
membrane have been related to altered APP processing, with
increased Ab production. Thus, the interaction between sortilin
and APP through the FLVHRY motif is vital for APP trafficking
and processing. However, more studies are needed to determine if
sortilin and this motif are directly involved in the amyloidogenic
pathway.
In conclusion, we are the first to demonstrate head-to-head and
tail-to-tail interactions between sortilin and APP. The FLVHRY
motif-mediated interaction is crucial for APP lysosomal and lipid
raft distribution, and may promote lysosome-dependent degrada-
Figure 10. Effect of sortilin on APP lysosomal degradation. APP
lysosomal targeting. HEK293 cells were co-transfected with APP-YFP
and sortilin-pcDNA3.1 constructs or pcDNA3.1 (mock DNA) plasmid in
1:1 molar ratio for 24 hours and then treated with DMSO or Bafilomycin
AI, a lysosomal inhibitor, (BafA1, 4 mM, Sigma) for 6 h [30]. Cell lysates
were harvested and APP level was examined by WB with mouse anti-
APP-N’ (22c11). Transfected APP-YFP served to monitor transfection
efficiency. The APP level was plotted after correction as to the
corresponding b-actin and transfection efficiency.
doi:10.1371/journal.pone.0063049.g010
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tion of APP. Our data provides new molecular insights into APP
trafficking and processing.
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